XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings/(Accumulated deficit)
Retained Earnings/(Accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Nonredeemable Noncontrolling Interests [Member]
Permanent Equity [Member]
Permanent Equity [Member]
Cumulative Effect, Period of Adoption, Adjustment
Convertible Preferred Stock
Retained Earnings/(Accumulated deficit)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Total Stockholders' Equity $ 809,855                        
Stockholders' Equity Attributable to Noncontrolling Interest                   $ 94,320      
Common stock     $ 334                    
Common stock, shares outstanding, start at Dec. 31, 2019     28,610,357                    
Balance, start at Dec. 31, 2019   $ (10)   $ 1 $ (284,301) $ 1,110,635 $ (5) $ (16,809) $ (10)   $ 904,175 $ (10)  
Preferred stock, shares outstanding, start at Dec. 31, 2019       120,750                  
Redeemable Non-controlling Interest, start at Dec. 31, 2019 391,275                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) attributable to Cowen Inc. 124,196             124,196     124,196    
Net income (loss) attributable to non-controlling interest in consolidated subsidiaries and funds, Non-Reedemable                   13,081 13,081    
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds (32,924)                        
Foreign currency translation (2)           (2)       (2)    
Capital contributions 184,223                 163,019 163,019    
Capital withdrawals (181,863)                 (48,995) (48,995)    
Increase in noncontrolling interest due to consolidation of entity (48,596)                 48,596 48,596    
Noncontrolling Interest, Decrease from Deconsolidation (360,711)                        
Restricted stock awards issued, shares     1,371,723                    
Purchase of treasury stock, at cost, shares     (3,487,439)                    
Purchase of treasury stock, at cost (49,834)       (49,834)           (49,834)    
Common stock issued during period, shares, acquisitions     74,694                    
Common stock issued during period, value, acquisitions 926   $ 0     926         926    
Preferred dividends paid (5,094)                   (5,094)   $ (5,094)
Dividends, Cash (4,144)             (4,144)     (4,144)    
Amortization of share based awards 35,287         35,287         35,287    
Common stock, shares outstanding, end at Sep. 30, 2020     26,569,335                    
Balance, end at Sep. 30, 2020       $ 1 (334,135) 1,146,848 (7) 98,139     1,181,201    
Preferred stock, shares outstanding, end at Sep. 30, 2020       120,750                  
Redeemable Non-controlling Interest, end at Sep. 30, 2020 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Total Stockholders' Equity 901,685                        
Stockholders' Equity Attributable to Noncontrolling Interest                   188,925      
Common stock     $ 334                    
Common stock, shares outstanding, start at Jun. 30, 2020     27,641,600                    
Balance, start at Jun. 30, 2020       $ 1 (314,971) 1,135,141 (5) 81,185     1,090,610    
Preferred stock, shares outstanding, start at Jun. 30, 2020       120,750                  
Redeemable Non-controlling Interest, start at Jun. 30, 2020 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) attributable to Cowen Inc. 20,284             20,284     20,284    
Net income (loss) attributable to non-controlling interest in consolidated subsidiaries and funds, Non-Reedemable                   9,232 9,232    
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds 0                        
Foreign currency translation (2)           (2)       (2)    
Capital contributions 0                 74,337 74,337    
Capital withdrawals 0                 (2,473) (2,473)    
Restricted stock awards issued, shares     88,811                    
Purchase of treasury stock, at cost, shares     (1,161,076)                    
Purchase of treasury stock, at cost (19,164)       (19,164)           19,164    
Preferred dividends paid (1,698)                   (1,698)   (1,698)
Dividends, Cash (1,632)             (1,632)     (1,632)    
Amortization of share based awards 11,707         11,707         11,707    
Common stock, shares outstanding, end at Sep. 30, 2020     26,569,335                    
Balance, end at Sep. 30, 2020       $ 1 (334,135) 1,146,848 (7) 98,139     1,181,201    
Preferred stock, shares outstanding, end at Sep. 30, 2020       120,750                  
Redeemable Non-controlling Interest, end at Sep. 30, 2020 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Total Stockholders' Equity 911,180                        
Stockholders' Equity Attributable to Noncontrolling Interest                   270,021      
Common stock     $ 334                    
Total Stockholders' Equity 969,497                        
Stockholders' Equity Attributable to Noncontrolling Interest 199,624                 199,624      
Common stock     $ 334                    
Common stock, shares outstanding, start at Dec. 31, 2020     26,845,628                    
Balance, start at Dec. 31, 2020 1,169,121     $ 1 (346,870) 1,130,138 (7) 185,901     1,169,121    
Preferred stock, shares outstanding, start at Dec. 31, 2020       120,750                  
Redeemable Non-controlling Interest, start at Dec. 31, 2020 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) attributable to Cowen Inc. 230,630             230,630     230,630    
Net income (loss) attributable to non-controlling interest in consolidated subsidiaries and funds, Non-Reedemable                   13,379 13,379    
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds 0                        
Foreign currency translation 5           5       5    
Capital contributions 0                 49,377 49,377    
Capital withdrawals 0                 (26,617) (26,617)    
Increase in noncontrolling interest due to consolidation of entity 0                        
Noncontrolling Interest, Decrease from Deconsolidation 0                 74,813 74,813    
Restricted stock awards issued, shares     1,879,397                    
Purchase of treasury stock, at cost, shares     (3,986,017)                    
Purchase of treasury stock, at cost (149,052)       (149,052)           (149,052)    
Debt Conversion, Converted Instrument, Shares Issued     2,938,841                    
Common stock issued during period, shares, acquisitions     56,801                    
Common stock issued during period, value, acquisitions 2,202   $ 0     2,202         2,202    
Preferred dividends paid (5,094)                   (5,094)   (5,094)
Dividends, Cash (9,388)             (9,388)     (9,388)    
Amortization of share based awards 44,327         44,327         44,327    
Common stock, shares outstanding, end at Sep. 30, 2021     27,734,650                    
Balance, end at Sep. 30, 2021 1,244,077     $ 1 (495,922) 1,176,667 (2) 402,049     1,244,077    
Preferred stock, shares outstanding, end at Sep. 30, 2021       120,750                  
Redeemable Non-controlling Interest, end at Sep. 30, 2021 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Total Stockholders' Equity 1,097,344                        
Stockholders' Equity Attributable to Noncontrolling Interest                   166,499      
Common stock     $ 334                    
Common stock, shares outstanding, start at Jun. 30, 2021     28,995,801                    
Balance, start at Jun. 30, 2021       $ 1 (438,671) 1,166,165 (2) 369,517     1,263,843    
Preferred stock, shares outstanding, start at Jun. 30, 2021       120,750                  
Redeemable Non-controlling Interest, start at Jun. 30, 2021 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) attributable to Cowen Inc. 37,803             37,803     37,803    
Net income (loss) attributable to non-controlling interest in consolidated subsidiaries and funds, Non-Reedemable                   (4,938) (4,938)    
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds 0                        
Foreign currency translation 0                        
Capital contributions 0                 2,539 2,539    
Capital withdrawals 0                 (3,150) (3,150)    
Restricted stock awards issued, shares     327,697                    
Purchase of treasury stock, at cost, shares     (1,588,848)                    
Purchase of treasury stock, at cost (57,251)       (57,251)           57,251    
Preferred dividends paid (1,698)                   (1,698)   $ (1,698)
Dividends, Cash (3,573)             (3,573)     (3,573)    
Amortization of share based awards 10,502         10,502         10,502    
Common stock, shares outstanding, end at Sep. 30, 2021     27,734,650                    
Balance, end at Sep. 30, 2021 1,244,077     $ 1 $ (495,922) $ 1,176,667 $ (2) $ 402,049     $ 1,244,077    
Preferred stock, shares outstanding, end at Sep. 30, 2021       120,750                  
Redeemable Non-controlling Interest, end at Sep. 30, 2021 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Total Stockholders' Equity 1,083,127                        
Stockholders' Equity Attributable to Noncontrolling Interest $ 160,950                 $ 160,950      
Common stock     $ 334